Attachment 1: Product Information for Actemra
ACTEMRA is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients: in combination with methotrexate (MTX) or other non-biological disease-modifying anti-rheumatic drugs (DMARDs) in case of either an inadequate response or intolerance to previous therapy with one or more DMARDs; or ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- national pbm monograph template rev20091005
- attachment 1 product information for actemra
- abstract university of manchester
- new biologic agents for juvenile rheumatoid arthritis
- ragiv gandhi university of health sciences
- comparative effectiveness of drug therapy for rheumatoid
- impact of inadequate adherence on response to
Related searches
- watershed information for kids
- new product ideas for students
- health information for senior citizens
- background information for science projects
- heart health information for seniors
- nutritional information for starbucks
- reverse mortgage information for dummies
- medical information for seniors
- 1 product website
- product information sheet sample
- product information sheet template
- product information sheet template free